β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.
β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.
复制标题
DOI:
10.1016/j.jhep.2018.04.004
复制
发表时间:
2018-09
影响因子:
25.7
通讯作者:
Mehal WZ
中科院分区:
文献类型:
--
作者:
Chen Y;Ouyang X;Hoque R;Garcia-Martinez I;Yousaf MN;Tonack S;Offermanns S;Dubuquoy L;Louvet A;Mathurin P;Massey V;Schnabl B;Bataller RA;Mehal WZ
Sterile inflammation resulting in alcohol hepatitis (AH) occurs unpredictably after many years of excess alcohol intake. The factors responsible for the development of AH are not known but mitochondrial damage with loss of mitochondrial function are common features. Hcar2 is a G-protein coupled receptor which is activated by β-hydroxybutyrate (BHB), and the relevance of the BHB-Hcar2 pathway in alcoholic liver disease is not known. We tested if loss of BHB production can result in increased liver inflammation. We further tested if BHB supplementation can protect in AH through interaction with Hcar2, and the immune and cellular basis for protection. Humans with AH have reduced hepatic BHB, and inhibition of BHB production in mice aggravated ethanol induced AH, with higher serum ALT levels, increased steatosis and greater neutrophil influx. Conversely supplementation of BHB had the opposite effects with reduced ALT levels, reduced steatosis and neutrophil influx. This therapeutic effect of BHB is dependent on the receptor Hcar2. BHB treatment increased liver IL-10 transcripts, and promoted the M2 phenotype of intrahepatic macrophages. BHB also increased the transcriptional level of M2 related genes in vitro bone marrow derived macrophages. This skewing towards M2 related genes is dependent on lower mitochondrial membrane potential (Δψ) induced by BHB. Collectively, our data shows that BHB production during excess alcohol consumption has an anti-inflammatory and hepatoprotective role through a Hcar2 dependent pathway, and introduces the concept of metabolite based therapy for AH.
登录
查看更多内容
DOI:
10.1161/atvbaha.116.307573
发表时间:
2016-07
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
Lin J;Hu Y;Nunez S;Foulkes AS;Cieply B;Xue C;Gerelus M;Li W;Zhang H;Rader DJ;Musunuru K;Li M;Reilly MP
通讯作者:
Reilly MP
影响因子:
2.2
作者:
Elliott, Simon;Smith, Christopher;Cassidy, Diane
通讯作者:
Cassidy, Diane
DOI:
10.1016/j.metabol.2014.11.007
发表时间:
2015-03
期刊:
Metabolism: clinical and experimental
影响因子:
--
作者:
Frisard MI;Wu Y;McMillan RP;Voelker KA;Wahlberg KA;Anderson AS;Boutagy N;Resendes K;Ravussin E;Hulver MW
通讯作者:
Hulver MW
影响因子:
13.5
作者:
Mandrekar, Pranoti;Bataller, Ramon;Tsukamoto, Hidekazu;Gao, Bin
通讯作者:
Gao, Bin
影响因子:
6.5
作者:
Clugston, Robin D.;Jiang, Hongfeng;Blaner, William S.
通讯作者:
Blaner, William S.